131 participants
EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-15
- Start Date:
- 2018-08-23
- Completion:
- 2025-08-12
Conditions
- Neuropsychiatric Systemic Lupus Erythematosus
- Systemic Lupus Erythematosus (SLE)
- Cognitive Impairment
Interventions
- DRUG
No Results Yet